The influence of β-blockers on delayed memory function in people with cognitive impairment

American Journal of Alzheimer's Disease and other Dementias

Volumn 22, Issue 1, 2007, Pages 57-61

  Gliebus, Gediminas ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adrenergic; Alzheimer's disease; CNS; Dementia; Memory; blocker

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; NORADRENALIN; PROPRANOLOL;

ADULT; AGED; ARTICLE; ASSOCIATION; BRAIN NUCLEUS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COGNITIVE DEFECT; ENVIRONMENTAL FACTOR; FEMALE; HIPPOCAMPUS; HUMAN; LOCUS CERULEUS; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; SIGNAL TRANSDUCTION; SPATIAL MEMORY;

EID: 33847416282     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317506295889     Document Type: Article

References (34)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
2. National Center for Health Statistics. Health, United States, 2005: the 29th report on the health status of the nation. Hyattsville, Md: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2005.
3. Murchinson CHF, Zhang X-Y, Zhang W-P, Ouyang M, Lee A, Thomas SA. A distinct role for norepinephrine in memory retrieval. Cell. 2004;117:131-143.
4. Bergles DE, Doze VA, Madison DV, Smith SJ. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J Neurosci. 1996;16:572-585.
5. Backman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 1999;52:1861-1870.
6. Devauges V, Sara SJ. Memory retrieval enhancement by locus coeruleus stimulation: evidence for mediation by beta-receptors. Behav Brain Res. 1991;43:93-97.
7. Hagan JJ, Alpert JE, Morris RG, Iversen SD. The effects of central catecholamine depletions on spatial learning in rats. Behav Brain Res. 1983;9:83-104.
8. Izquierdo I, Medina JH. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem. 1997;68:285-316.
9. O'Carroll RE, Drysdale E, Cahill L, Shajahan P, Ebmeier KP. Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man. Psychol Med. 1999;29:1083-1088.
10. Thomas SA, Palmiter RD. Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci. 1997;111:579-589.
11. Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature. 1994;371:702-704.
12. Gelinas JN, Nguyen PV. Beta-adrenergic receptor activation facilitates induction of a protein synthesis-dependent late phase of long-term potentiation. J Neurosci. 2005;25:3294-3303.
13. Aston-Jones G, Rajkowski J, Kubiak P. Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task. Neuroscience. 1997;80:697-715.
14. Aston-Jones G, Rajkowski J, Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res. 2000;126:165-182.
15. Hoogendijk WJ, Feenstra MG, Botterblom MH, et al. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann Neurol. 1999;45:82-91.
16. Nicholas AP, Pieribone VA, Hokfelt T. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience. 1993;56:1023-1039.
17. Fleming K, Kim SH, Doo M, Maguire G, Potkin SG. Memory for emotional stimuli in patients with Alzheimer's disease. Am J Alzheimers Dis Other Dement. 2003;18:340-342.
18. Perez-Stable EJ, Halliday R, Gardiner PS, et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am J Med. 2000;108:359-365.
19. Hajjar I, Catoe H, Sixta S, et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 2005;60:67-73.
20. Birkenhager WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 2001;161:152-156.
21. Farmer ME, Kiltner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J Clin Epidemiol. 1990;43:475-480.
22. Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol. 1999;56:991-996.
23. Darvesh S, Leach L, Black SE, Kaplan E, Freedman M. The behavioral neurology assessment. Can J Neural Sci. 2005;32:167-177.
24. Kim KW, Lee DY, Jhoo JH, et al. Diagnostic accuracy of Mini-Mental Status Examination and Revised Hasegawa Dementia Scale for Alzheimer's disease. Dement Geriatr Cogn Disord. 2005;19:324-330.
25. Wadworth AN, Murdoch D, Brogden R. Atenolol; a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 1991;42:468-510.
26. Prichard BN. Beta-blockage therapy and cardiovascular disease: past, present and future. Postgrad Med. 1988;Spec No:8-18.
27. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
28. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
29. Chui HC, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia. Arch Neurol. 2000;57:191-196.
30. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
31. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
32. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
33. Shua-Haim JR, Shua-Haim V, Comsti L, Ross JS. Donepezil (Aricept®) treatment of multi infarct dementia: The caregivers and clinical impression. Am J Alzheimers Dis Other Dement. 2000;15:201-211.
34. Middleton JI, Richardson S, Berman E. An assessment and intervention study of aggressive behavior in cognitively impaired institutionalized elderly. Am J Alzheimers Dis Other Dement. 1997;12:24-29.